Healthcare provider profile · identity verified

Paul Gebhard

Internal Medicine · SARATOGA SPRINGS, NY · NPI 1821187204

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	357	123
Rosuvastatin Calcium	Rosuvastatin Calcium	336	114
Lisinopril	Lisinopril	293	96
Levothyroxine Sodium	Levothyroxine Sodium	208	68
Amlodipine Besylate	Amlodipine Besylate	163	58
Tamsulosin Hcl	Tamsulosin Hcl	154	55
Losartan Potassium	Losartan Potassium	153	55
Omeprazole	Omeprazole	150	55
Escitalopram Oxalate	Escitalopram Oxalate	139	42
Metoprolol Succinate	Metoprolol Succinate	123	48
Gabapentin	Gabapentin	120	37
Allopurinol	Allopurinol	117	43
Simvastatin	Simvastatin	115	44
Jardiance	Empagliflozin	111	26
Glipizide Er	Glipizide	105	32
Ezetimibe	Ezetimibe	101	35
Atenolol	Atenolol	89	35
Metformin Hcl	Metformin Hcl	89	27
Sertraline Hcl	Sertraline Hcl	87	30
Eliquis	Apixaban	86	33
Metformin Hcl Er	Metformin Hcl	86	24
Pantoprazole Sodium	Pantoprazole Sodium	83	31
Hydrochlorothiazide	Hydrochlorothiazide	81	29
Albuterol Sulfate Hfa	Albuterol Sulfate	75	25
Bupropion Xl	Bupropion Hcl	75	21
Famotidine	Famotidine	73	29
Zolpidem Tartrate	Zolpidem Tartrate	73	18
Olmesartan Medoxomil	Olmesartan Medoxomil	62	23
Duloxetine Hcl	Duloxetine Hcl	54	16
Tradjenta	Linagliptin	54	12
Alprazolam	Alprazolam	51	23
Nifedipine Er	Nifedipine	50	17
Fluticasone Propionate	Fluticasone Propionate	49	22
Farxiga	Dapagliflozin Propanediol	47	12
Prednisone	Prednisone	44	18
Trazodone Hcl	Trazodone Hcl	44	16
Ozempic	Semaglutide	43	suppressed
Januvia	Sitagliptin Phosphate	39	14
Finasteride	Finasteride	38	16
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	12
Clonazepam	Clonazepam	36	12
Montelukast Sodium	Montelukast Sodium	35	suppressed
Naltrexone Hcl	Naltrexone Hcl	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	17
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	29	12
Ramipril	Ramipril	29	11
Potassium Chloride	Potassium Chloride	28	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	13
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	11
Metoprolol Tartrate	Metoprolol Tartrate	24	11
Synthroid	Levothyroxine Sodium	23	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Diazepam	Diazepam	21	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Furosemide	Furosemide	18	suppressed
Torsemide	Torsemide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Cephalexin	Cephalexin	16	12
Colchicine	Colchicine	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Fenofibrate	Fenofibrate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error